dexamethasone intravitreal implant 0.7 mg

DRUG5 trials

Sponsors

Allergan, JHSPH Center for Clinical Trials, G. d'Annunzio University

Conditions

Diabetic Macular EdemaMacular EdemaMacular OedemaRetinal Vein OcclusionUveitis

Phase 3

Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial

CompletedNCT02623426

JHSPH Center for Clinical TrialsMacular Edema, Uveitis

Start: 2017-03-09End: 2022-02-02Updated: 2023-07-10

Unknown Phase

Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)

CompletedNCT01411696

AllerganMacular Edema, Retinal Vein Occlusion

Start: 2011-07-31End: 2012-03-31Updated: 2013-04-16

A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO)

CompletedNCT01445626

AllerganMacular Edema

Start: 2011-10-31End: 2012-01-31Updated: 2013-02-18

Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion

CompletedNCT01566526

AllerganMacular Oedema, Retinal Vein Occlusion

Start: 2012-03-31End: 2012-06-30Updated: 2013-05-27

Ranibizumab Versus Dexamethasone Implant in Diabetic Macular Edema

CompletedNCT03385382

G. d'Annunzio UniversityDiabetic Macular Edema

Start: 2016-12-06End: 2017-06-27Updated: 2018-01-02

Related Papers

Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.

2015-09-0410 citations

Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study.

2015-04-0118 citations